It's the year 2050 and we are still waiting for Pelage to release the full phase 2 results of PP405 and start phase 3.
    Chat 1/24/2026

    At a glance
    In this general discussion post the tone is 😞 negative.

    Other terms

    Pelage plans to release phase 2 results and start phase 3 trials for PP405 in 2050, but skepticism remains due to past delays and unfulfilled promises. Users express frustration over the lack of progress in hair loss treatments, mentioning Minoxidil, finasteride, RU58841, CB-03-01, and Fluridil.
    View this post in the Community →

    Similar Community Posts Join

    5 / 434 results

      community PP405 Hairloss Reversal and Hairline Restoration

      in Treatment  5 upvotes 1 month ago
      PP405 may induce new hair growth but cannot revive completely dead follicles, and its effectiveness on hairlines is uncertain. It is expected to be available by mid-2028, but users are advised to manage expectations and consider using other treatments like minoxidil and finasteride.

      community Clascoterone 5% solution infographic

      in Update  130 upvotes 3 months ago
      Clascoterone 5% solution is discussed as a potential new treatment for hair loss, offering an alternative for those who can't use finasteride or need additional options beyond minoxidil. Concerns about cost, effectiveness, and safety compared to existing treatments like RU58841 and finasteride are highlighted.

      community How likely do you think it is for PP405 to come out?

      in Research/Science  21 upvotes 5 months ago
      PP405 is a potential new hair loss treatment that works through metabolic pathways rather than hormonal ones, with an estimated market release between late 2027 and 2029. Current alternatives to finasteride include minoxidil, pyralutamide, fluridil, and RU58841, with hair transplants also being a viable option.

    Related Research

    6 / 21 results